MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
Transcatheter Embolization for Trauma of the Pelvis
Concepts and techniques for a multidisciplinary treatment approach.
By Luke R. Wilkins, MD; Jaime All, MD; and J. Fritz Angle, MD
Your Perspectives
We asked several VDF and Coalition leadership volunteers to offer some perspectives on the VDF and its programs. Here is what they had to say.
Development of a Research Agenda for IVC Filters
A preliminary report from a multidisciplinary research consensus panel.
By John A. Kaufman, MD, FSIR
United States Enrollment Completed for OSPREY Trial of Terumo's Misago Stent to Treat SFA Disease
July 17, 2012—Terumo Interventional Systems (Somerset, NJ) announced the completion of patient enrollment in the United States in the OSPREY (Occlusive/Stenosis Peripheral Artery Revascularization Study) trial.
Vascular Trauma
By Claudio Schö,nholz, MD
Terumo's Misago Stent to Be Studied in US and Japan
May 12, 2010—Terumo Medical Corporation (Somerset, NJ) announced it has received an investigational device exemption conditional approval from the US Food and Drug Administration for OSPREY (Occlusive/Stenotic Peripheral Artery Revascularization Study), which will evaluate the safety and effectiveness of the Misago selfexpanding stent system for use in the superficial femoral artery.
Terumo's Misago Stent to Be Jointly Studied in US and Japan
May 12, 2010—Terumo Medical Corporation (Somerset, NJ) announced it has received an investigational device exemption conditional approval from the US Food and Drug Administration for OSPREY (Occlusive/Stenotic Peripheral Artery Revascularization Study), which will evaluate the safety and effectiveness of the Misago self-expanding stent system for use in the superficial femoral artery. The Misago system, which is commercially available in Europe, consists of a nitinol stent that is premounted on the distal portion of a rapid-exchange delivery catheter.
The Harmonization By Doing Initiative and the OSPREY Trial
An update on the evaluation of the Misago stent as part of the Harmonization By Doing regulatory collaboration between the United States and Japan.
By Srinivas Iyengar, MD, FACC
Creating CLI Teams
The VIVA Physicians' Vascular Leaders Forum offers guidance on core competencies and quality measures for establishing multidisciplinary CLI care teams.
By John H. Rundback, MD; Tony S. Das, MD; Peter A. Schneider, MD; and Michael R. Jaff, DO; on behalf of the VLF participants
The Decade in Vascular Trauma
The developments and data that have shaped modern vascular trauma care and what the next decade may hold.
By John Fritz Angle, MD, and James Forrest Calland, MD
Sex-Related Differences in Lower Extremity Peripheral Artery Disease
A review of differences in clinical presentation and outcomes after surgical revascularization and endovascular procedures in women as compared with men.
By Maureen P. Kohi, MD, FSIR, and John Fritz Angle, MD, FSIR
Vascular Intervention and Women's Health
By Maureen P. Kohi, MD, FSIR
Adopting Radial Access
A review of preparation, technique, and postprocedure considerations when using transradial access.
By Ramon Quesada, MD, FACP, FACC, FSCAI
Plaque Excision for Treatment of Restenosis
Use of a novel device for recurrent stenosis in the superficial femoral artery.
By Barry S. Weinstock, MD
Sponsored by Gore & Associates
The Pathophysiology of Arteriovenous Graft Thrombosis and Stenosis
Understanding the underlying challenges of an optimal access site.
With Mitchell Henry, MD
TRA for Hemodialysis Access Interventions
Transradial access options in dysfunctional hemodialysis fistula management.
By John H. Rundback, MD, FSVM, FAHA, FSIR, and Kevin “Chaim” Herman, MD
